1-3 of 3
Sherry Pierce, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of FMS-Like Tyrosine Kinase-3 Mutations on Prognosis in Acute Myeloid Leukemia: A Single Institution Experience between 2000 and 2007.

Hady A. Ghanem, MD, Dan Jones, MD, Hagop M. Kantarjian, MD, Stefan Faderl, MD, Elihu H. Estey, MD, Sherry Pierce, MD, Susan O’Brien, MD, Jorge Cortes, MD, Farhad Ravandi, MD
Journal: Blood
Blood (2007) 110 (11): 3489.
https://doi.org/10.1182/blood.V110.11.3489.3489
Published: 2007
Journal Articles

Comorbidity Scoring Using the Hematopoetic Cell Transplantation Comorbidity Index (HCTCI) Is Predictive of Early Death Rate and Event Free Survival (EFS) in Patients over 60 Years of Age Receiving Induction Therapy for Acute Myeloid Leukemia (AML).

Francis Giles, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Stefan Faderl, MD, Srdan Verstovsek, MD, Sherry Pierce, MD, Elias Jabbour, MD, Jorge Cortes, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2006) 108 (11): 1975.
https://doi.org/10.1182/blood.V108.11.1975.1975
Published: 2006
Journal Articles

Characteristics and Prognosis of Patients (pts) with Acute Megakaryocytic Leukemia (AMegL) Treated at M.D. Anderson Cancer Center Since 1987.

Yasuhiro Oki, MD, Elihu Estey, MD, Hagop Kantarjian, MD, Jorge Cortes, MD, Stefan Faderl, MD, Susan O’Brien, MD, Charles Koller, MD, Miloslav Beran, MD, Michael J. Keating, MD, Sherry Pierce, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2004) 104 (11): 3003.
https://doi.org/10.1182/blood.V104.11.3003.3003
Published: 2004